(Q46907760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

idiopathic pulmonary arterial hypertension

15 January 2020

main subject

0 references

author

Olivier Sitbon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marc Humbert

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Xavier Jais

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6

Gérald Simonneau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

Ségolène Cabrol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

Steeve Provencher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

23 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

European Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

589-595

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16431875%20AND%20SRC:MED&resulttype=core&format=json

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Survival with first-line bosentan in patients with primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Haemodynamic evaluation of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI728